MoneyWorks4Me

Neuland Laboratories informs about outcome of board meeting

22 Nov 2017 Evaluate

Neuland Laboratories has informed about the Board of Directors at their meeting held on November 22, 2017, has approved the Unaudited financial results and limited review report by the auditors for the quarter ended September 30, 2017; and the appointment of Amit Agarwal as the Chief Financial officer (CFO) of the Company in place of D. Saharsh Rao with effect from November 22, 2017.  D.Saharsh Rao shall continue in his role as the Joint Managing Director of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..